Skip to main content

Find Clinical Trials

Home
Conditions
Leukemia

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,415 public trials 1,033 recruiting studies

Refine in advanced search Browse all conditions

Leukemia trial results

Completed

Study to Assess the Safety and Tolerability of AZD1152 in Combination With Low Dose Cytosine Arabinoside (LDAC)

NCT00926731

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Research Site Cleveland, Ohio, United States

Research Site Houston, Texas, United States

Research Site Le Chesnay, France

Research Site Villejuif, France

View Trial Details

Completed

High Dose Daunorubicin Vs. Standard Dose Daunorubicin in Induction Treatment of AML

NCT00474006

Conditions: Acute Myelogenous Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Asan Medical Center Seoul, Songpa-gu, South Korea

View Trial Details

Completed

A Trial Comparing a Prophylactic With a Therapeutic Platelet Transfusion Strategy in Two Groups

NCT00521664

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +4 more
Locations: Klinikum Nürnberg Nord; Einheit für Knochenmarktransplantation; 5. Med. Klinik Nuremberg, Germany

View Trial Details

Completed

Safety and Tolerability Open Label Dose Escalation Study of Acadesine in B-CLL Patients

NCT00559624

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations: Hematology Department, ZNA Stuivenberg Antwerp, Belgium

Cliniques universitaires Saint-Luc Haematology Dept Brussels, Belgium

Hematology Department UZ Gasthuisberg Leuven, Belgium

Hôpital Avicenne Bobigny, France

View Trial Details

Completed

5-azacytidine Valproic Acid and ATRA in AML and High Risk MDS

NCT00339196

Conditions: Acute Myelogenous Leukaemia (AML), Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations: Chu Saint Louis Paris, France

View Trial Details

Completed

Arsenic Trioxide in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

NCT00193518

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations: Tennessee Oncology, PLLC Nashville, Tennessee, United States

View Trial Details

Completed

Pemetrexed and Oxaliplatin in Treating Patients With Metastatic Solid Tumors or Lymphoma

NCT00470405

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +47 more
Locations: Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Completed

Study of Dasatinib (BMS-354825) in Patients With Accelerated Phase Chronic Myeloid Leukemia

NCT00101647

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +12 more
Locations: Local Institution Birmingham, Alabama, United States

Local Institution Anaheim, California, United States

Local Institution Los Angeles, California, United States

Local Institution Stanford, California, United States

View all 70 locations

View Trial Details

Completed

Protecting Young Special Risk Females From Cervical Cancer Through Human Papilloma Virus (HPV) Vaccination

NCT00964210

Conditions: Arthritis, Arthritis, Juvenile, Autoimmune Diseases, +43 more
Locations: Royal Childrens Hospital Melbourne, Victoria, Australia

View Trial Details

Completed

Dasatinib (BMS-354825) in Subjects With Lymphoid Blast Phase Chronic Myeloid Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

NCT00101595

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +18 more
Locations: Local Institution Birmingham, Alabama, United States

Local Institution Anaheim, California, United States

Local Institution Los Angeles, California, United States

Local Institution Stanford, California, United States

View all 60 locations

View Trial Details